Krishnamurthy P Gudehithlu, Peter Hart, Amit Joshi, Ignacio Garcia-Gomez, David J Cimbaluk, George Dunea, Jose A L Arruda and Ashok K Singh
Krishnamurthy P Gudehithlu1*, Peter Hart1,2, Amit Joshi1,2, Ignacio Garcia-Gomez3,4, David J Cimbaluk2, George Dunea1,4, Jose A L Arruda1,3 and Ashok K Singh1,3,4
1Division of Nephrology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, United States
2Department of Internal Medicine, Rush University Medical College, Chicago, IL, United States
3Section of Nephrology, University of Illinois at Chicago, Chicago, IL, United States
4The Hektoen Institute of Medicine, Chicago, IL, United States
Received date: December 05, 2018; Accepted date: December 19, 2018; Published date: December 24, 2018
Citation: Gudehithlu KP, Hart P, Joshi A, Gomez IG, Cimbaluk DJ, et al. (2018) Urine Exosomal Ceruloplasmin a Potential Early Biomarker of Underlying Kidney Disease. J Clin Exp Nephrol Vol 3:20. doi: 10.21767/2472-5056.100071
Copyright: © 2018 Gudehithlu KP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The article entitled “Urine Exosomal Ceruloplasmin a Potential Early Biomarker of Underlying Kidney Disease,” has been accepted for publication in the Journal of Clinical & Experimental Nephrology considering the statements provided in the article as personal opinion of the author which was found not having any conflict or biasness towards anything. As the article was a perspective one, information provided by the author was considered as an opinion to be expressed through publication.
Publisher took decision to make the article online solely based on the reviewers suggestion which considered the article not but a personal opinion of the author. However, it is found that the author have some personal concerns and issues, therefore, being retracted from the journal.